. 2023 Mar 29;13(7):3054–3066. doi: 10.1016/j.apsb.2023.03.022

Table 3.

Effect of 9a‒9g on WT HIV-1 RT.

Compd.	IC₅₀ (μmol/L)^a	Compd.	IC₅₀ (μmol/L)^a
9a	0.035 ± 0.008	9f	0.021 ± 0.006
9b	0.027 ± 0.002	9g	0.021 ± 0.001
9c	0.021 ± 0.008	NVP	0.404 ± 0.07
9d	0.033 ± 0.002	EFV	0.030 ± 0.02
9e	0.029 ± 0.003	ETR	0.011 ± 0.01

IC₅₀: inhibitory concentration of test compound required to inhibit wild-type HIV-1 reverse transcriptase polymerase activity by 50%. Values are the mean ± SD of at least two parallel tests. The data were obtained from the same laboratory (Prof. Erik De Clercq, Rega Institute for Medical Research).